Back

Validation of a novel high-sensitivity cardiac troponin assay.

28 August 2022 (17:15 - 18:00)
Organised by:
Congress Presentation Part of: Predicting risks Biomarkers ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Ingar Ziad Restan

Stavanger University Hospital, Stavanger (Norway)

7 More presentations in this session

Presentation thumbnail
Prevalence of reaching target low-density lipoprotein cholesterol (LDL-C) in very high-risk patients using high intensity lipid-modifying therapy.
Mr A. Omar Khader (Antwerpen, BE)
Abstract Slides
Presentation thumbnail
Exploring adherence to an early rule-out pathway for myocardial infarction in the emergency department using mixed-methods
Doctor A. Ferry (Edinburgh, GB)
Abstract Slides
Presentation thumbnail
Performance of high-sensitivity cardiac troponin T versus I for the early diagnosis of myocardial infarction
Doctor L. Koechlin (Zurich, CH)
Abstract Slides
Presentation thumbnail
An acoustic based risk score in addition to pre-test probability estimation for coronary artery disease improves risk classification in patients with suspected coronary artery disease
Doctor L. Bjerking (Copenhagen, DK)
Abstract Slides
Presentation thumbnail
Impacts on the short-term outcome of patients with Tako-Tsubo syndrome
Miss R. Mousavi (Rochester, US)
Abstract Slides

Access the full session

Session thumbnail
Predicting risks

The Event

Event poster

ESC Congress 2022

28 August 2022 17:15 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources